Two negative randomized controlled trials in lupus: now what?
Open Access
- 8 May 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (28)
- https://doi.org/10.3410/m1-28
Abstract
Two negative randomized controlled trials in lupus: now what?This publication has 23 references indexed in Scilit:
- B cell depletion therapy for 19 patients with refractory systemic lupus erythematosusArchives of Disease in Childhood, 2008
- Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future – the EULAR recommendations for the management of SLE and the use of end-points in clinical trialsLupus, 2008
- Treating patients with lupus with B-cell depletionLupus, 2008
- Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trialsRheumatology, 2008
- EULAR points to consider for conducting clinical trials in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2008
- Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous systemAnnals Of The Rheumatic Diseases, 2006
- Clinical trial design in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2006
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Short-lived Plasmablasts and Long-lived Plasma Cells Contribute to Chronic Humoral Autoimmunity in NZB/W MiceThe Journal of Experimental Medicine, 2004
- The role of B cells in lpr/lpr-induced autoimmunity.The Journal of Experimental Medicine, 1994